other dosage forms:
needed effects
olanzapine
active ingredient
zyprexa intramuscular
unwanted side effects
medical attention
following side effects
taking olanzapine
check
doctor
olanzapine side effects
medical attention
body
medicine
side effects
health care professional
side effects
following side effects
post-injection delirium/sedation syndrome
collection of signs
symptoms
olanzapine
active ingredient
zyprexa intramuscular
overdose
been reported following injections of the extended-release im suspension
events
injections
patients
receiving injections
months
onset of events
injection
hours
majority of patients
required supportive care
including intubation
deaths
been reported occurring
days
receiving
appropriate dose of the extended-release im suspension
patients
high olanzapine blood levels
death
study
cause of the elevated drug levels in these deaths
inconclusive results
drug safety communication
us food
drug administration
study in animals
drug level increases
death
possibility that the deaths
entry of the drug
bloodstream
seizures
patients
im
extended-release suspension
patients
receiving oral olanzapine
somnolence
patients
receiving im
extended-release suspension
sedation
adolescents
drug in short term schizophrenia
disorder
clinical trials
stopping
discontinuation symptoms
sweating
insomnia
tremor
anxiety
nausea
vomiting
somnolence
headache
sedation
dizziness
post-injection delirium/sedation syndrome
dysarthria
tremor
hypertonia
abnormal gait
parkinsonismuncommon
seizures
cerebrovascular accident
ataxia
stupor
dystonia
tardive dyskinesia
amnesiarare
coma
neuroleptic malignant syndrome
discontinuation symptoms
orthostatic hypotensioncommon
ecg
hypertension
postural hypotension
chest pain
tachycardia
peripheral edemauncommon
syncope-related events
vasodilation
bradycardiarare
ventricular tachycardia/fibrillation
sudden deathpostmarketing reports
venous thromboembolic events
collective data
placebo-controlled clinical studies
n =-rrb-
use of atypical antipsychotic agents
including olanzapine
treatment of behavioral disorders in the elderly patient with dementia
risk of death
times
drug
treated patient
placebo
treated patient
average length of duration for the trials
weeks with the cause of death in the majority of cases
heart failure
sudden death
pneumonia
nature
olanzapine
fda for use in the treatment of behavioral disorders in elderly patients with dementia
increased weight
appetite
elevated cholesterol
elevated glucose
elevated triglyceridesfrequency
hyperglycemia
ketoacidosis
hyperosmolar coma
deathpostmarketing reports
diabetic coma
diabetic ketoacidosis
olanzapine
greater association than some other atypical antipsychotics
increasing glucose levels
mean increases
mg/dl
differences in mean changes in serum glucose
patients with evidence of glucose dysregulation at baseline
analysis of patients
months of therapy
rate on increase in mean blood glucose
months
significant alterations in lipids
been observed including serum triglyceride elevations
mg/dl
long-term studies
weeks in adults
baseline in mean fasting cholesterol
ldl
triglycerides
mg/dl
mg/dl
mg/dl
mean increases in fasting lipid values
total cholesterol
ldl
triglycerides
patients without evidence of lipid dysregulation at baseline
placebo-controlled monotherapy trials
olanzapine-treated patients
average of kg
average kg weight loss in placebo patients
baseline weight
baseline
placebo
significant weight gain
baseline bmis
longer term exposure
least weeks
weight gain
weight gain
appetite
adolescents
drug in short term schizophrenia
disorder
clinical trials
n
placebo patients
events at a rate
dry mouth
constipation
dyspepsia
abdominal pain
diarrhea
flatulence
nausea
toothache
vomiting
toothache
tongue edemarare
ileus
intestinal obstructionpostmarketing reports
pancreatitis
nausea
dry mouth
dose
year
old man
fecal incontinence
following initiation of treatment with olanzapine mg
effect
patient
next scheduled exam
days after initiation of therapy
point olanzapine
fecal incontinence
hours
organic cause for fecal incontinence
rectal exam
sigmoidoscopy results
lab tests
normal limits
increased hepatic enzymesuncommon
alkaline phosphatase increases
bilirubinemia
hypoproteinemia rare
fatty liver depositpostmarketing reports
jaundice
asymptomatic elevations of hepatic transaminases
treatment
nasopharyngitis
upper respiratory tract infection
cough
nasal congestion
pharyngolaryngeal pain
sneezing
rhinitis
pharyngitis
pneumoniauncommon
epistaxisrare
lung edema
hyperprolactinemiauncommon
decreased libido
breast pain
clinical studies
changes in prolactin levels
dose
higher doses
higher levels of prolactin
study
weeks
plasma prolactin concentrations
upper limit of normal
uln
patients
normal baseline prolactin values
majority of these elevations
uln
ecchymosis
eosinophilia
leukopenia
neutropeniauncommon
thrombocytopenia
dry eyes
abnormality of accommodation
amblyopiarare
mydriasis
akathisia
asthenia
ear pain
fatigue
pyrexia
chills
hypersensitivitypostmarketing reports
allergic reaction
vaginal dischargeuncommon
amenorrhea
decreased/increased menstruation
impotence
menorrhagia
metrorrhagia
polyuria
urinary frequency
urinary retention
urinary urgency
urination impairedvery
postmarketing reports
priapism
arthralgia
pain
muscle spasms
musculoskeletal stiffness
joint pain
extremity painrare
osteoporosispostmarketing reports
rhabdomyolysis
acneuncommon
face edema
photosensitivity reaction
alopeciapostmarketing reports
drug reaction with eosinophilia
systemic symptoms
dress
rash
insomnia
abnormal dreams
auditory hallucination
restlessness
disorder
abnormal thinking
personality disorder
insomniauncommon
personality disorder
suicide attempt
collection of adverse reactions
term personality disorder
data on nonaggressive objectionable behavior
common adverse reactions
immediate-release products
postural hypotension
constipation
weight gain
dizziness
personality disorder
akathisia
common adverse reactions
extended-release im injection
headache
sedation
weight gain
cough
diarrhea
pain
nausea
somnolence
dry mouth
nasopharyngitis
appetite
vomiting
injection site painrare
injection site abscess
side effects of zyprexa intramuscular
fda
healthcare professional for medical advice
intramuscular powder for solution
intramuscular powder for suspension
release
bloating
swelling of the face
arms
hands
lower legs
feet
blurred vision
change in vision
change
walking
balance
clumsiness or unsteadiness
difficulty with speaking
difficulty with swallowing
drooling
impaired vision
inability
loss of balance control
mask-like face
muscle
jerking
stiffness
moving
rapid weight gain
restlessness
shuffling walk
slowed movements
slurred speech
stiffness of the arms
legs
jerky
movements of the head
face
mouth
neck
tingling of the hands
feet
trembling
shaking of the fingers
hands
feet
legs
arms
twisting movements of the body
uncontrolled movements
face
neck
unusual weight gain
loss
bladder pain
cloudy urine
bruising
burning
crawling
itching
numbness
prickling
pins
needles
tingling feelings
chest pain
breathing
burning
painful urination
dizziness
excessive muscle tone
frequent urge
headache
inability
eyes
spasms of the eyelid
itching of the vagina
genital area
lack of coordination
purplish patches in the skin
loss of bladder control
loss of memory
side pain
muscle tension
tightness
nervousness
pain during sexual intercourse
pounding in the ears
problems with memory
rhythmic movement of the muscles
pounding
irregular heartbeat
pulse
speaking
sticking
tongue
white vaginal discharge with no odor
mild odor
tightness in the chest
twitching
uncontrolled twisting movements of the neck
trunk
arms
legs
incomplete body
facial movements
weakness of the arms
legs
acid
sour stomach
back pain
belching
change in personality
difficulty
bowel movement
stool
discouragement
feeling
fever
heartburn
increased appetite
increased cough
indigestion
lack of appetite
lack
loss of strength
loss of interest
pleasure
runny nose
sneezing
stomach discomfort
pain
stuffy nose
thirst
trouble sleeping
trouble with concentrating
watering of the mouth
blemishes on the skin
body aches
pain
chills
cold sweats
congestion
cough
dry skin
dryness
soreness of the throat
unusual sense of well-being
heavy menstrual bleeding
periods
hoarseness
joint pain
lack of feeling
emotion
leg cramps
pain in the arms
legs
pimples
sweating
tender
swollen glands in the neck
uncaring feelings
voice change
vomiting